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Abstract 
Objective: Several risk factors for late aortic events in patients with uncomplicated type B aortic 
dissection (UTBAD) have been reported; however, they remain controversial. We developed and 
validated a new risk prediction score system for late aortic events in patients with UTBAD. 
Methods: We reviewed 187 consecutive patients diagnosed with UTBAD from 2004 to 2017 at 2 
centers (derivation cohort) and 219 consecutive patients diagnosed with UTBAD from 2012 to 2016 in 
4 other centers (validation cohort). We explored predictors of late aortic events using Fine-Gray 
generalisation of the proportional hazards model, then developed a risk prediction score model and 
determined the test reliability using time-dependent receiver operating characteristic (ROC) analyses. 
Finally, we validated the model using external multicenter data. 
Results: The risk prediction score system was developed using the following independent predictors: 
initial aortic diameter of ≥40 mm (2 points), false lumen diameter > true lumen diameter (2 points), 
ulcer-like projection (1 point), and age of ≥70 years (1 point). ROC analysis showed that a cut-off total 
additive score of 2 points. In the validation cohort, the low-risk group (score of 0-1 points) demonstrated 
lower 1- and 3-year incidence rates of late aortic events than the high-risk group (score of 2-6 points) 
(0.9% vs 32.5% and 0.9% vs 47.1%, respectively; p<0.0001).  
Conclusions: We developed a simple risk prediction score system for late aortic events in patients with 
UTBAD. High-risk patients can be identified using our model, and they should be closely monitored 
and considered for interventions at the appropriate timing.  
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Abbreviations and Acronyms 
UTBAD: uncomplicated type B aortic dissection 
TEVAR: thoracic endovascular aortic repair 
BMT: best medical treatment 
CT: computed tomography 
ULP: ulcer-like projection 
HR: hazard ratio 
CI: confidence interval 
ROC: receiver operating characteristic 
 
INTRODUCTION 
  Late aortic events in patients with uncomplicated acute Stanford type B aortic dissection (UTBAD) 
have poor outcomes.1 About 25% to 50% of patients who survive the acute phase require open or 
endovascular aortic surgery for the dissected aorta in the chronic phase.2,3 Many reports have described 
thoracic endovascular aortic repair (TEVAR) for patients with UTBAD in the chronic phase; however, 
the indication and timing have not been well established.4,5 Two randomized trials compared the 
outcomes between best medical treatment (BMT) and BMT with TEVAR in patients with UTBAD. The 
ADSORB trial randomized 61 patients with UTBAD and indicated that additional TEVAR in the acute 
term is superior to medical therapy alone in terms of thrombosis of the false lumen in patients with 
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UTBAD; however, it showed no benefit of TEVAR in terms of mortality, prevention of aortic rupture, 
or dilatation.2 The Instead-XL trial randomized 140 patients with UTBAD and revealed that the TEVAR 
group demonstrated a high thrombosis rate of the false lumen (90.6%) and that the 5-year aorta-related 
mortality rate was lower in the TEVAR group than BMT alone group (6.9% vs 19.3%, respectively; 
p=0.04).6 However, the 2-year aorta-related mortality rate was higher in the TEVAR group than BMT 
alone group (6.9% vs 2.9%, respectively). This unfavorable early outcome in the TEVAR group may 
have occurred because TEVAR was performed in all randomized patients with UTBAD without risk 
stratification. Patients at low risk of late aortic events might not receive clinical benefits of pre-emptive 
TEVAR. Which patients should undergo pre-emptive TEVAR remains controversial. 
  Many risk factors for late aortic events have been identified7-15; however, a robust risk model 
predicting late aortic events after UTBAD has not been established. This study was performed to build 
a risk prediction score model for late aortic events in patients with UTBAD and validate it using large-
size clinical data with a high follow-up rate. 
     
METHODS 
Study design and setting 
We performed two retrospective cohort studies of a risk prediction score system for late aortic events 
in patients with UTBAD. The derivation cohort study enrolled 187 patients diagnosed with UTBAD 
from 2004 to 2017 in 2 centers (Chiba Central Medical Center and Seikeikai Chiba Medical Center). 
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The validation cohort study enrolled 219 patients diagnosed with UTBAD from 2012 to 2016 in 4 other 
centers (Kurashiki Central Hospital, New Tokyo Hospital, Sakakibara Heart Institute, and Tokyo Bay 
Urayasu Ichikawa Medical Center) (Fig. 1). 
  This study was approved by the Institutional Review Boards of Seikeikai Chiba Medical Center, 
Chiba University, Kurashiki Central Hospital, New Tokyo Hospital, Sakakibara Heart Institute, and 
Tokyo Bay Urayasu Ichikawa Medical Center. A waiver of informed consent was obtained.  
Derivation cohort study 
From October 2004 to December 2017, 242 consecutive patients were diagnosed and treated for 
Stanford type B aortic dissection at Chiba Central Medical Center and Seikeikai Chiba Medical Center.  
  We excluded 9 patients with non-acute Stanford type B aortic dissection who had been diagnosed ≥2 
weeks after the onset of symptoms. We also excluded 46 patients with complicated type B aortic 
dissection (rupture, impending rupture, and/or malperfusion). We retrospectively reviewed 187 
consecutive patients with UTBAD. The latest follow-up research, including telephone and letter 
interviews for some outpatients in other clinics, was conducted from January 2018 to May 2018. The 
median follow-up duration was 41 months (25th percentile [Q1]:16, 75th percentile [Q3]:72), the 
complete follow-up rate was 96.8%, and six patients were lost to follow-up. 
  The diagnosis was made with contrast-enhanced computed tomography (CT) in all patents. Aortic 
dissection was classified according to the Stanford classification as type B if the dissection did not 
involve the ascending aorta. We included type B intramural hematoma in the study group because it 
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was difficult to distinguish between intramural hematoma and aortic dissection with a totally 
thrombosed false lumen.16 We described our acute aortic dissection protocol in a past study.7 All cases 
of UTBAD were managed medically regardless of the false lumen status or the aortic diameter. Medical 
management included admission to the intensive care unit, continuous blood pressure monitoring, 
central venous access for intravenous antihypertensive medication, and urine output monitoring. We 
routinely followed up the dissected aorta with contrast-enhanced CT at 1 day, 7 days, and 2 weeks after 
admission unless a patient had renal dysfunction. Systolic blood pressure was controlled between 100 
and 120 mmHg. We also closely monitored patients after discharge and tried to maintain their systolic 
blood pressure at <120 mmHg; however, strict blood pressure control was not achieved in 103 patients 
(55.1%) at 1 year after the diagnosis. During follow-up, contrast-enhanced CT scans were performed at 
3 to 6 months, 1 year, and annually thereafter. 
Validation cohort study 
The validation cohort comprised 242 consecutive patients who were diagnosed and treated for acute 
UTBAD at Kurashiki Central Hospital, New Tokyo Hospital, Sakakibara Heart Institute, and Tokyo 
Bay Urayasu Ichikawa Medical Center from January 2012 to December 2016. We excluded 23 patients 
who were not followed up for >3 months. We retrospectively reviewed 219 consecutive patients with 
UTBAD. The median follow-up duration was 36 months (Q1:22, Q3:50). 
Before analysis of the validation data, the scoring system was developed from the derivation set as 
described below. We calculated predictive scores for each patient using clinical data obtained from the 
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medical records; we also collected data on the presence and timing of late aortic events from the medical 
records.  
Data collection and definitions 
  All clinical data were retrospectively collected from each patient’s medical record during in-hospital 
or regular outpatient visits. UTBAD was defined as follows: the absence of malperfusion (any newly 
developed symptom with the presence of false lumen expansion that impaired true lumen flow on the 
CT images), no aortic rupture, and no continuous symptom despite optimal medical treatment with 
analgesics and/or antihypertensive medication). In-hospital mortality was defined as any death before 
discharge. 
  We measured the aortic diameter and false lumen thickness and patency on all CT images. The largest 
long axis and short axis diameters and false lumen thickness were measured at five different portions 
according to the zone system described in our past study7 (Fig. 2). The initial aortic diameter was 
defined as the largest short axis diameter of the dissected aorta on CT at admission. A patent false lumen 
was defined as any contrast effect in the false lumen in the early or late vascular phase, excluding ulcer-
like projections (ULPs). An ULP was defined as a focal, well-defined pouch of contrast medium 
measuring ≤10 mm in length and projecting into the non-communicating false lumen along the long 
axis of the aorta. The median age was 68 years old (Q1:60, Q3:75) in the derivation cohort, and 70 years 
old (Q1:61, Q3:78) in the validation cohort. Then we set 70 years old as division point between younger 
patients and older patients. 
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  Late aortic events were defined as follows: late open surgery or TEVAR for the dissected aorta after 
discharge from initial diagnosis and medical management, rupture or impending rupture, ≥55-mm 
dilatation of the dissected aorta, rapid dilatation of the dissected aorta (>5 mm per 6 months), and 
saccular aneurysm. 
Aortic-related mortality was defined as death from aortic rupture, sudden unexplained death, or death 
from a newly developed acute Stanford type A aortic dissection.  
Statistical analysis 
Summary statistics for the patient characteristics and CT data were constructed using frequency and 
proportion for categorical data and mean and standard deviation or median and 25th (Q1) and 75th (Q3) 
percentile, as appropriate, for continuous variables. Univariate analyses were carried out to test the 
association between potential predictors and late aortic events using the t-test or the Mann–Whitney U-
test for continuous variables and Fisher’s exact test for categorical variables. All potential predictors as 
shown in Table 1 were entered into the univariate analyses; the variables with a p-value of <0.05 and 
the major variables showed in previous literature were then selected for the multivariate model to detect 
the risk factors for late aortic events.   
  For time-to-late aortic event outcomes, the competing risk analysis was performed with the Fine-
Gray generalisation of the proportional hazards model accounting for death as a competing risk. The 
cumulative incidence curves were estimated by the Aalen-Johansen estimator.17 Death is a competing 
risk of loss to follow-up: patients who die can no longer become lost to follow-up. Competing risks are 
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defined as events that prevent the outcome of interest from occurring. 
  To identify baseline and clinical variables associated with overall survival time, a multivariate 
analysis was performed using the Fine-Gray generalisation of the proportional hazards model with the 
following covariates: age of ≥70 years, male sex, initial aortic diameter of ≥40 mm, patent false lumen, 
ULP, false lumen diameter > true lumen diameter, and systolic blood pressure of ≥120 mmHg during 
follow-up (Table 2). We selected these seven covariates based on our clinical experience and previous 
literature to detect the risk factors for late aortic events.3,7-14 
We constructed a simple predictive score system including the significant variables from the Fine-
Gray generalisation of the proportional hazards model. The reference value was set from the average β 
coefficients of two variables that were closest to zero. The score was then assigned from the β coefficient 
of each variable divided by the reference value (0.696). Time-dependent ROC analysis was then applied 
to the risk scores. 
All comparisons were planned, and the tests were two-sided. A p-value of <0.05 was considered 
statistically significant. All statistical analyses were initially performed using SAS version 9.4 (SAS 
Institute Inc., Cary, NC), SPSS version 22.0 (IBM Corp., Armonk, NY), and R version 3.00.  
 
RESULTS 
Derivation cohort study 
The patients’ characteristics, initial admission data, and CT data are presented in Table 1. The median 
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duration of stay in the intensive care unit was 2 days (Q1:1, Q3:3), and the median duration of 
hospitalization was 16 days (Q1:14, Q3:20). The in-hospital mortality rate was 0.5% (n=1). One patient 
died of respiratory failure. During the follow-up, 37 (19.9%) patients died. The cause of death was a 
late aortic event in 21 patients (56.8%) and a non-aortic event in 16 patients (43.2%). The actuarial 
survival rates were 96.3% at 1 year, 89.8% at 3 years, and 81.9% at 5 years (Fig. 3a).  
Seventy-five patients (40.1%) developed late aortic events during the follow-up. An operation for the 
dissected aorta was performed in 49 patients (26.2%). The reasons for the operation were ≥55-mm 
dilatation of the aorta in 22 patients, rapid dilatation of the aorta (>10 mm per year) in 18 patients, 
dilatation of a ULP in 8 patients, and new development of an acute Stanford type A aortic dissection in 
1 patient. Thirty-two patients underwent open aortic surgery: descending aorta replacement in 17 
patients, total aortic arch replacement with the frozen elephant trunk technique in 6 patients, total aortic 
arch replacement without the frozen elephant trunk technique in 4 patients, staged descending aorta 
replacement in 3 patients, and abdominal aortic replacement in 2 patients. Seventeen patients underwent 
TEVAR for the dissected descending aorta.  
  During follow-up, 26 patients refused surgery despite having a ≥55-mm dissected aorta or a saccular 
aneurysm; 10 (38.5%) of them died. The cumulative incidence rates of late aortic events were 24.2% at 
1 year, 38.1% at 3 years, and 44.5% at 5 years (Fig. 3b).   
Risk prediction score system for late aortic events in patients with UTBAD  
From the Fine-Gray generalisation of the proportional hazards model, the following four variables 
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were identified as significant risk factors: initial aortic diameter of ≥40 mm (HR, 4.11; 95% CI, 2.34–
7.20; p<0.01), false lumen diameter > true lumen diameter (HR, 4.21; 95% CI, 2.29–7.74; p<0.01), 
ULP (HR, 2.10; 95% CI, 1.16–3.49; p=0.01), and age of ≥70 years (HR, 1.92; 95% CI, 1.17–3.14; 
p=0.01). These four factors were incorporated into the risk prediction score using the integer point 
values from the β coefficient and reference value of each variable as described above (Table 2). The 
scores ranged from 0 to 6 points. Receiver operating characteristic (ROC) analysis showed that a cut-
off score of 2 points had a sensitivity of 92.0% and specificity of 61.6% (area under the curve, 0.83; 
p<0.001). All ROC analysis results are shown in Table 3, and the ROC curve is shown in Figure 4a. 
The low probability group (score of 0–1) demonstrated lower 1- and 3-year incidence rates of late aortic 
events than the high probability group (score of 2–6) (5.7% vs 40.8% and 7.4% vs 57.6%, respectively; 
p<0.0001) (Fig. 5a). 
Validation cohort study 
The patients’ characteristics and initial CT data are presented in Table 4. Late aortic events occurred 
in 52 (23.7%) of all patients. The median length to late aortic events was 10 months (Q1:5, Q3:16). A 
late operation for the dissected aorta was performed in 31 (26.2%) patients. During follow-up, 21 
patients refused surgery despite having a ≥55-mm dissected aorta or a saccular aneurysm. 
Time-dependent ROC analysis showed that a cut-off score of 2 points had a sensitivity of 96.2% and 
specificity of 69.5% (area under the curve, 0.85; p<0.001). All ROC analysis results are shown in Table 
5, and the ROC curve is shown in Figure 4c. The low probability group (score of 0–1) demonstrated 
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lower 1- and 3-year incidence rates of late aortic events than the high probability group (score of 2–6) 
(0.9% vs 32.5% and 0.9% vs 47.1%, respectively; p<0.0001) (Fig. 5b).  
Comparison of derivation and validation sets 
The variables included in the scoring system were compared between the derivation and validation 
cohorts and are presented in Table 6. There were more patients with an initial aortic diameter of >40 
mm and thereby more high-risk patients (score of 2–6) in the derivation than validation cohort (59.9% 
vs 46.1%, respectively; p=0.004). The cumulative incidence curves estimated that the 1- and 3-year 
aortic event incidence rates were 24.2% and 38.1%, respectively, in the derivation cohort and were 
15.6% and 22.9%, respectively, in the validation cohort (p=0.510) (Fig. 6). Although the differences 
between the two cohorts were not statistically significant, the derivation cohort showed higher late 
aortic event rates than the validation cohort, which was compatible with the different patient profiles 
in the two cohorts.  
 
COMMENT 
Several studies have identified certain clinical factors, laboratory findings, and imaging findings as 
predictors of late aortic events after UTBAD that can be used to define high-risk UTBAD.7-15 However, 
all of these studies used a relatively small sample from a single center, and none of them validated their 
risk factors. Moreover, previous studies selected too many risk factors and suggested a relatively 
complex risk prediction method. Therefore, we developed a simple risk prediction score system for late 
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aortic events in patients with UTBAD and validated it using multicenter data. Our study included 187 
patients in the derivation cohort and 219 patients in the validation cohort, which is a larger sample size 
than in any previous studies. We identified four risk factors from the multivariate analysis of our 
derivation cohort data (initial aortic diameter of ≥ 40 mm, false lumen diameter > true lumen diameter, 
ULP, and age of ≥70 years) and built a simple additive risk score system. Importantly, these variables 
are very easy to collect and the risk score is very easy to calculate.  
The cut-off total additive risk score was 2 points. The finding of an initial aortic diameter of ≥40 mm 
or false lumen diameter > true lumen diameter automatically indicates a high risk for late aortic events 
regardless of the patient’s age and presence of ULP. Many studies have suggested imaging factors as 
the major predictors of late aortic events. Patients with a large aorta from the beginning and/or a rapidly 
expanding aorta may have a high risk of late aortic events. The initial aortic diameter has been identified 
as one of the most important predictors of late aortic events, and the cut-off initial aortic diameter was 
40 mm in our previous study7 and most previous studies. 8,14 Tsai et al.15 suggested that the connection 
between the true lumen and false lumen influences the false lumen flow volume and flow blood pressure 
and affects the aortic diameter expansion during the follow-up period. The aortic growth rate is not 
linear; it is faster in the early phase than in the late phase, and a faster aortic growth rate is associated 
with increased aortic events.18 The various relationships between the true lumen and the false lumen 
have also been reported as predictors of late aortic events. Factors in these relationships include the size 
of the intimal tear,8 number of intimal tears9 or position of intimal tears,10 false lumen thickness,11 
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elliptic configuration of the true lumen,10 patent false lumen,12 partial thrombosed false lumen,13 
position of the false lumen,10 and areas with localized dissection or ULP.12,14 In addition, Tolenaar et 
al.10 reported that the configuration of the false lumen reflects the pressure inside it and that an elliptical 
configuration of the true lumen in combination with a circular formation of the false lumen is associated 
with increased aortic growth. Some of these factors can be difficult to detect in some cases.19 However, 
the finding of a larger false lumen diameter than true lumen diameter is easy to detect on CT images in 
any case. 
Even without two important imaging findings, older patients with UTBAD and ULP should be 
considered to be at high risk of late aortic events. However, some previous studies showed that younger 
patients were at higher risk of aortic events.10,14 This discrepancy could be explained by our inclusion 
of some patients with intramural hematoma, which is generally difficult to differentiate from aortic 
dissection with a completely thrombosed false lumen. Older age of 70 years has been identified as a 
predictor of disease progression in patients with type B intramural hematoma.12 The same study showed 
that ULP was a risk factor for disease progression in patients with type B intramural hematoma. In 
addition, several studies have identified clinical predictors of late aortic events such as Marfan 
syndrome and white race.3,8,20 No patients in our cohorts had Marfan syndrome, and no race diversity 
was present; this might have contributed to the discrepancy in the results between previous studies and 
our study. We found some differences in the patients’ profiles between the derivation and validation sets. 
The proportion of patients with an initial aortic diameter of ≥40 mm was significantly higher in the 
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derivation than validation cohort (39.0% vs 26.9%, respectively; p=0.011). Thereafter, the proportion 
of high-risk patients (score of 2–6) was significantly higher in the derivation than validation cohort 
(59.9% vs 46.1%, respectively; p=0.004). Because we included different hospitals in different regions 
in the validation cohort, it seems natural that some differences were present in the patients’ aortic 
profiles between the two cohorts. The variability in the measurement of CT findings could be one reason 
for the different patient profiles between the two cohorts. Mendoza et al.21 reported that the method by 
which the aortic diameter is measured on the axial CT slice results in a 3- to 5-mm difference in the 
aortic diameter. They indicated that the aortic three-dimensional view or double oblique slice is the 
most reliable way to measure the aortic diameter.21 Although we used the axial CT slice to measure the 
aortic diameter, we believe that the variability in measurement in our study was minimal because we 
strictly defined the measurement method and our method was easy to perform. 
Limitations 
The present study has several limitations. In this study, we employed both type B aortic dissection 
with a thrombosed false lumen and type B intramural hematoma because these conditions were difficult 
to distinguish, as mentioned above. This is an important limitation because the natural evolution of 
intramural hematoma and aortic dissection are very different. This was an observational study 
performed at two centers in the derivation phase and at four centers in the validation phase in Japan, 
and the sample size and variables were limited. We lost 23 (9.5%) patients to follow-up at >3 months 
in the validation cohort, and we excluded them from the analysis. This was not selective drop-out, and 
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the sample size was kept at the previous study level. A large prospective study and external validation 
study in regions other than Japan are needed to determine the accuracy of this risk prediction score and 
further clarify the definition of high-risk UTBAD.  
 
CONCLUSIONS 
In conclusion, we developed a simple risk prediction score system for late aortic events in patients 
with UTBAD. The cut-off risk prediction score was set at 2 points, which revealed the following factors 
associated with a high risk of UTBAD: initial aortic diameter of ≥40 mm, false lumen diameter > true 
lumen diameter at admission, ULP, age of ≥70 years. Moreover, the positive predictive value was higher 
by combining these factors. We should closely monitor patients with these factors and consider 
intervention at the appropriate time. 
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Figure and Figure Legends 
Figure 1. Flow diagram of the entire series of Stanford Type B aortic dissection. 
 
The study comprised 187 patients in the derivation cohort and 219 patients in the validation cohort. 
We had 75 cases with late aortic events in the derivation cohort and 52cases with late aortic events in 
the validation cohort. Late aortic events were defined as follows: late open surgery or TEVAR for the 
dissected aorta, rupture or impending rupture, ≥55-mm dilatation of the dissected aorta, rapid dilatation 
of the dissected aorta (>5 mm per 6 months), and saccular aneurysm. 
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Figure 2. CT measurement technique. 
 
The diagnosis of aortic dissection was made with contrast-enhanced CT in all patients. We used the CT 
images at admission. We measured the aortic diameter and checked for false lumen patency on all CT 
images. The largest long-axis and short-axis diameters and false lumen thickness were measured at five 
sites according to a previously reported “zone” system: Zone 3 (distal aortic arch), Zone 4 (proximal 
descending aorta; T6 approximates the midpoint of the descending aorta), Zone 5 (distal descending 
aorta), Zone 6 to 7 (proximal abdominal aorta; celiac artery to renal artery), and Zone 8 to 9 (distal 
abdominal aorta; infrarenal artery). Usually, we used the axial view for the short-axis diameter. We also 
used the sagittal view or coronal view for the false lumen thickness and long-axis diameter because 
evaluation of the long-axis cross section of the aorta depends on the patient’s bloodstream. The initial 
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aortic diameter was defined as the largest short-axis diameter from any of the five sites. 
 
Figure 3. Cumulative incidence curves in the derivation cohort. 
 
(a) Cumulative incidence of freedom from all-cause death having no relation to aortic events in the 
derivation cohort with the confidence limits as a colored shaded area. The actuarial survival rates were 
96.3% at 1 year, 89.8% at 3 years, and 81.9% at 5 years. (b) Cumulative incidence of late aortic events 
in the derivation cohort with the confidence limits as a colored shaded area. The cumulative incidence 
rates of late aortic events were 24.2% at 1 year, 38.1% at 3 years, and 44.5% at 5 years. 
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Figure 4. Receiver operating characteristic (ROC) curve analysis. 
 
The risk prediction score system for late aortic events was developed using the following independent 
predictors: initial aortic diameter of ≥40 mm (2 points), false lumen diameter > true lumen diameter (2 
points), ulcer-like projection (1 point), and age of ≥70 years (1 point). ROC curve analysis showed a 
cut-off score of 2 points in both (a) the derivation cohort (area under the curve (AUC), 0.83; p<0.001) 
and (c) the validation cohort (AUC, 0.85; p<0.001). We also revealed the time related AUC by using 
the time related ROC analysis in both (b) the derivation cohort and (d) the validation cohort to assess 
the predictive accuracy of the risk score model.  
 
 
 24 
 
Figure 5. The cumulative incidence curves of late aortic events using the cumulative incidence method 
in each cohort. 
 
(a) The cumulative incidence rates of late aortic events in patients with a prediction score of 0-1 and 2-
6 points in the derivation cohort (p<0.0001). (b) The cumulative incidence rates of late aortic events in 
patients with a prediction score of 0-1 and 2-6 points in the validation cohort (p<0.0001). We also 
revealed the confidence limits as a colored shaded area in the both figures. The high-risk group (score 
of 2-6 points) was consist of patients with initial aortic diameter of ≥40 mm (2 points), false lumen 
diameter > true lumen diameter (2 points), ulcer-like projection (1 point) and age of ≥70 years (1 point). 
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Figure 6. The late aortic events cumulative incidence curve in the both cohorts.  
 
There was not significantly difference of the late aortic events cumulative incidence rates between 
patients in the derivation cohort and patients in the validation cohort (p=0.510). We also revealed the 
confidence limits as a colored shaded area in the figure. 
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Figure 7; The graphical abstract.  
 
Risk score system for late aortic evens in patients with uncomplicated type B aortic dissection. 
The risk prediction score system was developed using the following independent predictors: initial 
aortic diameter of ≥40 mm (2 points), false lumen diameter > true lumen diameter (2 points), ulcer-like 
projection (1 point), and age of ≥70 years (1 point). Receiver operating characteristic analysis showed 
that a cut-off total additive score of 2 points. The patients with total additive score of 2-6 points were 
high-risk group of late aortic events. In the validation cohort, the low-risk group (score of 0-1 points) 
demonstrated lower 1- and 3-year incidence rates of late aortic events than the high-risk group (score 
of 2-6 points) (0.9% vs 32.5% and 0.9% vs 47.1%, respectively; p<0.0001). 
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Table 1. Patients’ characteristics and CT data early after onset in the derivation cohort 
 
Variables All patients 
(n=187) 
Late aortic events (+) 
(n=75) 
Late aortic events (−) 
(n=112) 
Age, years 66.9±12.1 66.2±12.0 67.3±12.2 
Male 130 (69.5) 60 (80.0) 70 (62.5) 
Hypertension 185 (98.9) 75 (100) 110 (98.2) 
Hyperlipidemia 43 (23.0) 14 (18.7) 29 (25.9) 
Diabetes mellitus 17 (9.1) 7 (9.3) 10 (8.9) 
Hemodialysis 5 (2.7) 1 (1.3) 4 (3.6) 
Peripheral artery disease 12 (6.4) 7 (9.3) 5 (4.5) 
Coronary artery disease 26 (13.9) 10 (13.3) 16 (14.3) 
Cerebral infarction 14 (7.5) 7 (9.3) 7 (6.3) 
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Chronic obstructive pulmonary disease 16 (8.6) 3 (4.0) 13 (11.6) 
De Bakey classification: type IIIa 64 (34.2) 28 (37.3) 36 (32.1) 
De Bakey classification: type IIIb 123 (65.8) 47 (62.7) 76 (67.9) 
Patent false lumen at admission 100 (53.5) 40 (53.3) 60 (53.6) 
Initial aortic diameter of ≥40 mm  73 (39.0) 51 (68.0) 22 (19.6) 
False lumen diameter > true lumen diameter  47 (25.1) 28 (37.3) 19 (16.7) 
Ulcer-like projection  38 (20.3) 22 (29.3) 16 (14.3) 
Systolic blood pressure of ≥120 mmHg 1 year after onset 103 (55.1) 48 (64.0) 55 (49.1) 
Data are presented as n (%) or mean ± standard deviation. 
DeBakey IIIa: aortic dissection stops above the diaphragm; DeBakey IIIb: aortic dissection extends below the diaphragm  
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Table 2. Univariate and multivariate analyses for predictors of late aortic events in the derivation cohort 
Predictors Univariate Multivariate Score (points) 
 p value Hazard ratio (95% CI) p value β coefficient  
Age of ≥70 years  0.066 1.918 (1.171–3.142) 0.009 0.651 1 
Male sex 0.063 1.165 (0.598–2.269) 0.652   
Patent false lumen 0.653 0.692 (0.396–1.210) 0.197   
Initial aortic diameter of ≥40 mm <0.001 4.108 (2.343–7.203) <0.001 1.412 2 
False lumen diameter > true lumen diameter 0.002 4.207 (2.286–7.742) <0.001 1.436 2 
Ulcer-like projection 0.012 2.100 (1.161–3.485) 0.009 0.741 1 
Systolic blood pressure of ≥120 mmHg 1 year after onset 0.209 1.330 (0.806–2.194) 0.264   
CI: confidence interval. 
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Table 3. Prediction score results and receiver operating characteristic analysis in the derivation phase 
Score  Number of patients Number of late 
aortic events 
Sensitivity (%) Specificity (%) Positive predictive 
value (%) 
Negative predictive 
value (%) 
0 36 1 100 0.0 40.1 0.0 
1 39 5 98.7 31.3 49.0 97.2 
2 41 19 92.0 61.6 61.6 92.0 
3 49 31 66.7 81.3 70.4 78.4 
4 16 14 25.3 97.3 86.4 66.1 
5 5 5 6.7 99.1 83.3 61.3 
6 1 0 0.0 99.1 0.0 59.7 
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Table 4. Patients’ characteristics and CT data early after onset in the validation cohort 
 
Variables All patients 
(n=219) 
Late aortic events (+) 
(n=52) 
Late aortic events (−) 
(n=167) 
Age, years 68.0±13.5 67.0±13.5 68.3±13.5 
Age of ≥70 years 115 (52.5) 29 (55.8) 86 (51.5) 
Initial maximal minor axis aortic diameter (mm) 37.3±5.7 42.8±6.0 35.6±4.4 
Initial aortic diameter of ≥40 mm  59 (26.9) 36 (69.2) 23 (13.8) 
False lumen diameter > true lumen diameter  42 (19.2) 19 (36.5) 23 (13.8) 
Ulcer-like projection  46 (21.0) 12 (23.1) 34 (20.4) 
Data are presented as n (%) or mean ± standard deviation. 
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Table 5. Prediction score results and receiver operating characteristic analysis in the validation phase 
Score  Number of patients Number of late 
aortic events 
Sensitivity (%) Specificity (%) Positive predictive 
value (%) 
Negative predictive 
value (%) 
0 44 1 100 0.0 23.7 0.0 
1 74 1 98.1 25.7 29.1 97.7 
2 42 15 96.2 69.5 49.5 98.3 
3 35 23 67.3 85.6 59.3 89.4 
4 20 9 23.1 92.8 50.0 79.5 
5 4 3 5.8 994 75.0 77.2 
6 0 0 0.0 - - - 
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Table 6. Comparison of variables included in the scoring system between the derivation and validation cohorts 
Variables All patients 
(n=406) 
Patients in the 
derivation cohort 
(n=187) 
Patients in the 
validation cohort 
(n=219) 
p value 
Age, years 67.5±12.9 66.9±12.1 68.0±13.5 0.396 
Age of ≥70 years 200 (49.3) 85 (45.5) 115 (52.5) 0.164 
Initial maximal minor axis aortic diameter (mm) 37.8±6.2 38.3±6.7 37.3±5.7 0.091 
Initial aortic diameter of ≥40 mm  132 (32.5) 73 (39.0) 59 (26.9) 0.011 
False lumen diameter > true lumen diameter  89 (21.9) 47 (25.1) 42 (19.2) 0.151 
Ulcer-like projection  84 (20.7) 38 (20.3) 46 (21.0) 0.903 
Number of patients with score of ≥2 213 (52.5) 112 (59.9) 101 (46.1) 0.004 
Number of patients with late aortic events 127 (31.3) 75 (40.1) 52 (23.7) <0.001 
Data are presented as n (%) or mean ± standard deviation. 
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